In this interview, Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses the emergence of JAK inhibitors in myelofibrosis.
In this interview, Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses the emergence of JAK inhibitors in myelofibrosis.